REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search-icon
News

Sheba Helps to Save Lives in Samoa

Save Lives in Samoa
Since October, approximately 4,700 cases of measles have been diagnosed in Samoa, a tiny nation in the Pacific Islands. By December 10, the death toll in Samoa from this epidemic reached 70 people – 87% of whom were four years old or younger. The Samoan government shut the nation down last week in an attempt to curb the spread of the deadly epidemic

The World Health Organization urgently called upon Sheba Medical Center’s Israel Center for Disaster Medicine and Humanitarian Response Unit to send a team to help with this crisis. The high number of Samoan patients requiring intensive care treatment has overwhelmed the hospital wards and staff, and other countries have been asked to provide medical assistance.

A team of about 10 Israeli doctors and intensive care nurses from Sheba Medical Center traveled to Samoa and were deployed at Tupua Tamasese Meaole Hospital. The emergency team is being led by Dr. Itai Pessach, Head of Sheba’s Edmond and Lily Safra Children’s Hospital, and Assaf Luttinger, RN, Deputy Director of Sheba’s Israel Center for Disaster Medicine and Humanitarian Response. Their team also includes a pediatric pulmonologist, who is a specialist that the Samoan hospital does not have.

“Our goal is to help the people of Samoa and represent the State of Israel,” said Yitshak Kreiss, Director General of Sheba.

Related

Ayelet’s Miracle: The First Woman to Conceive Four Children Following Ovarian Tissue Cryopreservation

At 21, Ayelet Rozenberg was diagnosed with Hodgkin’s lymphoma. Facing aggressive therapies necessary to save her life, Ayelet feared she would never be able to…
Read More
bowel disease
News Sep 07.

Sheba Partners with Biomica to Advance Inflammatory Bowel Disease Care

As part of the new collaboration, Sheba and Biomica will engage in joint microbiome clinical research to develop better treatments for inflammatory bowel disease (IBD)…
Read More
Hemophilia research
News Sep 05.

New Sheba Study Indicates: Novel Treatment Sharply Reduces Bleed Rates Among Hemophilia Patients

Results indicate that a monthly treatment with Fitusiran significantly reduces bleed rates among both hemophilia A and B patients.
Read More